Jeffrey A. Meyerhardt

Jeffrey A. Meyerhardt is Professor of Medicine at Harvard Medical School and Chief Clinical Research Officer at Dana-Farber Cancer Institute, where he co-directs the Colon and Rectal Cancer Center. His research focuses on gastrointestinal cancers, including colon, pancreatic, and gastric cancers. He completed his MD at Yale and residency at Beth Israel Deaconess Medical Center.

His work examines clinical interventions for gastrointestinal malignancies, with emphasis on improving survival outcomes through innovative therapies. Recent studies investigate immune checkpoint inhibitors and lifestyle factors in cancer management.

Awards include the Tisch Outstanding Achievement Award and George P. Canellos Award for clinical excellence. His research has been profiled in major medical journals and informs national treatment guidelines.